Skip to main content
. 2021 Jul 14;11:720125. doi: 10.3389/fonc.2021.720125

Figure 3.

Figure 3

The overall survival analysis of immune checkpoints in KIRC. (A) The overall survival curve of CTLA4 in KIRC patients with high and low CTLA4 expression, and the risk score, survival status and gene expression of each patients, as well as time-dependent ROC. (B) The overall survival curve of HAVCR2 in KIRC patients with high and low HAVCR2 expression, and the risk score, survival status and gene expression of each patients, as well as time-dependent ROC. (C) The overall survival curve of CD274 in KIRC patients with high and low CD274 expression, and the risk score, survival status and gene expression of each patients, as well as time-dependent ROC. (D) The overall survival curve of LAG3 in KIRC patients with high and low LAG3 expression, and the risk score, survival status and gene expression of each patients, as well as time-dependent ROC.